2146
D. J. Cane-Honeysett et al. / Tetrahedron 61 (2005) 2141–2148
the general procedure above with isopropyl alcohol 10a
(300 mL, 3.93 mmol), 1,2,4-dithiazolidine-3,5-dione 4
(110 mg, 0.82 mmol) and betaine 7 (345 mg, 0.84 mmol)
in dichloromethane (2 cm3) gave 2a (74 mg, 51%). as a
colourless oil. Data as reported previously.8
4.2.6. (G)-4-Cyclohex-2-enyl-1,2,4-dithiazolidine-3,5-
dione 2f. Using the general procedure above with (G)-2-
cyclohexen-1-ol 10f (67 mL, 0.68 mmol), 1,2,4-dithiazo-
lidine-3,5-dione 4 (110 mg, 0.82 mmol) and betaine 7
(345 mg, 0.84 mmol) in dichloromethane (2 cm3) gave 2f
(56 mg, 38%), as a white solid; (Found MHC (CI)
216.0158, C8H10NO2S2 requires 216.0153); mp 89–91 8C;
nmax (thin film)/cmK1 2980–2740 (w), 1646 (s), 1296 (m),
1167 (m) and 1134 (m); dH (400 MHz; CDCl3) 1.62–2.25
(6H, complex, (CH2)3), 4.98–5.11 (1H, m, alkene CH), 5.46
(1H, dd, JZ2, 12 Hz, NCH) and 5.89–6.01 (1H, m, alkene
CH); dC (100.6 MHz; CDCl3) 21.8, 24.0, 25.5 ((CH2)3),
56.3 (NCH), 124.4, 131.4 (alkene CH) and 167.3 (C]O);
m/z (CI) 216 (MHC, 16%), 164 (36), 136 (100) and 123 (24).
4.2.2. S-4-sec-Butyl-1,2,4-dithiazolidine-3,5-dione 2b.
Using the general procedure above with R-sec-butyl alcohol
10b (67 mL, 0.73 mmol), 1,2,4-dithiazolidine-3,5-dione 4
(110 mg, 0.82 mmol) and betaine 7 (345 mg, 0.84 mmol)
in dichloromethane (2 cm3) gave 2b (74 mg, 51%) as a
colourless oil, 71% ee (determined by chiral HPLC); [a]D21
C24 (cZ1, CHCl3); nmax (thin film)/cmK1 3044–2883 (w),
1736 (s), 1646 (s), 1454 (m), 1311 (w), 1223 (m), 1189 (w),
1034 (w), 949 (m) and 692 (s); dH (300 MHz; CDCl3) 0.86
(3H, t, JZ8 Hz, CH3CH2), 1.42 (3H, d, JZ8 Hz, CH3CH),
1.72–1.84 (1H, m, CHAHB), 1.94–2.06 (1H, m, CHAHB) and
4.39–4.49 (1H, m, CH); dC (100.6 MHz; CDCl3) 14.2, 17.4
(CH3), 32.3 (CH2) and 56.6 (CH); m/z (EI) 191 (MC, 12%),
135 (14), 99 (21), 73 (100) and 64 (33).
4.2.7. E-4-But-2-enyl-1,2,4-dithiazolidine-3,5-dione 2g.
Using the general procedure above with crotyl alcohol
10g (commercial E/Z mixture, 59 mL, 0.69 mmol), 1,2,4-
dithiazolidine-3,5-dione 4 (110 mg, 0.82 mmol) and betaine
7 (345 mg, 0.84 mmol) in dichloromethane (2 cm3) gave 2g
(74 mg, 57%), as a yellow oil; (Found MHC (CI) 189.9998,
C6H8NO2S2 requires 189.9996); nmax (thin film)/cmK1
3060–2960 (m), 1718 (s), 1656 (m), 1420 (w), 1360 (w),
1340 (w), 1290 (m), 1140 (w), 1020 (w), and 980 (w); dH
(400 MHz; CDCl3) 1.70 (3H, dd, JZ1, 6 Hz, CH3), 4.28
(2H, dd, JZ1, 7 Hz, CH2), 5.38–5.55 (1H, m, alkene CH)
and 5.76–5.89 (1H, m, alkene CH); dC (100.6 MHz; CDCl3)
17.7 (CH3), 47.7 (CH2), 122.1, 132.9 (2!alkene CH) and
167.3 (C]O); m/z (CI) 190 (MHC, 16%), 164 (18), 136
(100) and 98 (8). 1H NMR indicated that the product
contained a small quantity of Z-4-but-2-enyl-1,2,4-dithiazo-
lidine-3,5-dione (E/Z ratioZ12:1). The only 1H NMR
signals for this stereoisomer which could be positively
identified were: dH (400 MHz; CDCl3) 1.74 (3H, d, JZ
6 Hz, CH3) and 4.40 (2H, d, JZ7 Hz, CH2).
4.2.3. S-4-(1-Methylheptyl)-1,2,4-dithiazolidine-3,5-
dione 2c. Using the general procedure above with R-2-
octanol 10c (120 mL, 0.76 mmol), 1,2,4-dithiazolidine-3,5-
dione 4 (110 mg, 0.82 mmol) and betaine 7 (345 mg,
0.84 mmol) in dichloromethane (2 cm3) gave 2c (142 mg,
76%) as a brown oil, enantiomers inseparable by chiral
HPLC; [a]2D1 C14 (cZ1, CHCl3); (Found MC (EI)
247.3810, C10H17NO2S2 requires 247.3795); nmax (thin
film)/cmK1 3030–2834 (w), 1734 (s), 1685 (s), 1516 (w),
1375 (w), 1221 (m), 1136 (w) and 1059 (w); dH (300 MHz;
CDCl3) 0.87 (3H, t, JZ8 Hz, CH3CH2), 1.11–1.36 (8H,
complex, (CH2)4) 1.45 (3H, d, JZ8 Hz, CH3CH), 1.55–1.79
(1H, m, CHAHBCH), 1.94–2.12 (1H, m, CHAHBCH) and
4.42–4.58 (1H, m, CH); dC (75.1 MHz; CDCl3) 14.0, 17.3
(CH3), 22.5, 26.5, 28.8, 31.6, 32.2 ((CH2)5), 56.6 (CH) and
167.7 (C]O); m/z (EI) 247 (MC, 7%), 155 (13), 135 (11),
129 (44) and 64 (100).
4.2.8. (G)-4-(1-Methylallyl)-1,2,4-dithiazolidine-3,5-
dione 2h and E/Z-4-but-2-enyl-1,2,4-dithiazolidine-3,5-
dione 2g. Using the general procedure above with (G)-3-
buten-2-ol 10h (64 mL, 0.74 mmol), 1,2,4-dithiazolidine-
3,5-dione 4 (110 mg, 0.74 mmol) and betaine 7 (345 mg,
0.84 mmol) in dichloromethane (2 cm3) gave a 2:1 mixture
of 2h and 2g (55 mg, 39%), as an oil; (Found MHC (CI)
189.9998, C6H8NO2S2 requires 189.9996); nmax (thin film)/
cmK1 2926 (w), 1734 (m), 1686 (s), 1516 (w), 1311 (w), and
1059 (w); For 2h: dH (400 MHz; CDCl3) 1.56 (3H, d, JZ
6.8 Hz, CH3), 5.00–5.08 (1H, m, NCH), 5.25–5.31 (2H,
complex, CH]CH2) and 6.07–6.18 (1H, m, CH]CH2); dC
(100.6 MHz; CDCl3) 16.8 (CH3), 57.4 (CH), 118.6
(CH]CH2), 134.5 (CH]CH2) and 167.2 (C]O); Data
for 2g as described above with the E/Z ratio being 1:2.
4.2.4. 4-Benzyl-1,2,4-dithiazolidine-3,5-dione 2d. Using
the general procedure above with benzyl alcohol 10d
(70 mL, 0.68 mmol), 1,2,4-dithiazolidine-3,5-dione 4
(110 mg, 0.82 mmol) and betaine 7 (345 mg, 0.84 mmol)
in dichloromethane (2 cm3) gave 2d (74 mg, 80%) as an
off-white solid. Data as reported previously.20
4.2.5. S-4-(1-Phenylethyl)-1,2,4-dithiazolidine-3,5-dione
2e. Using the general procedure above with R-a-methyl-
benzyl alcohol 10e (90 mL, 0.75 mmol), 1,2,4-dithiazo-
lidine-3,5-dione 4 (110 mg, 0.82 mmol) and betaine 7
(345 mg, 0.84 mmol) in dichloromethane (2 cm3) gave 2e
(90 mg, 50%), as a brown oil, 70% ee (determined by
chiral HPLC); [a]D21 K32 (cZ1, CHCl3); (Found MHC (CI)
240.0168, C10H10NO2S2 requires 240.0153); nmax (thin
film)/cmK1 3033–2844 (w), 1732 (s), 1630 (m), 1595 (m),
1554 (m), 1505 (w), 1426 (w), 1297 (m), 1190 (w), 1024 (w)
and 723 (m); dH (400 MHz; CDCl3) 1.78 (3H, d, JZ7 Hz,
CH3), 5.73 (1H, q, JZ7 Hz, CH) and 7.24–7.44 (5H,
complex, phenyl-H); dC (100.6 MHz; CDCl3) 16.0 (CH3),
57.6 (CH), 128.3, 128.7, 128.9 (phenyl CH), 137.9 (phenyl
ipso-C) and 167.8 (C]O); m/z (CI) 240 (MHC, 9%), 192
(9), 164 (18), 151 (100) and 47 (87).
4.2.9. R-Methyl 2-(3,5-dioxo-1,2,4-dithiazolidin-4-
yl)propionate 2i. Using the general procedure above with
S-methyl lactate 10i (65 mL, 0.68 mmol), 1,2,4-dithiazoli-
dine-3,5-dione 4 (110 mg, 0.82 mmol) and betaine 7
(345 mg, 0.84 mmol) in dichloromethane (2 cm3) gave 2i
(78 mg, 52%), as an oil, 92% ee (determined by chiral
HPLC); [a]2D1 C44 (cZ1, CHCl3). All other data as
described previously for racemic 2i.8
4.2.10. R-Ethyl 3-(3,5-dioxo-1,2,4-dithiazolidin-4-yl)-
butyrate 2j. Using the general procedure above with